Praveen Chandrasekharan1, Satyan Lakshminrusimha2, Dhuly Chowdhury3, Krisa Van Meurs4, Martin Keszler5, Haresh Kirpalani6, Abhik Das3, Michele C Walsh7, Elisabeth C McGowan5, Rosemary D Higgins8,9. 1. Division of Neonatology, Department of Pediatrics, UBMD, University at Buffalo, Buffalo, New York; pkchandr@buffalo.edu. 2. Department of Pediatrics, University of California at Davis, Sacramento, California. 3. Biostatistics and Epidemiology Division, RTI International, Rockville, Maryland. 4. Division of Neonatal and Developmental Medicine, Department of Pediatrics, School of Medicine, Stanford University, Palo Alto, California. 5. Department of Neonatology, Brown University, Providence, Rhode Island. 6. Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 7. Division of Neonatology, Department of Pediatrics, School of Medicine, Case Western Reserve University, Cleveland, Ohio. 8. Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland; and. 9. Department of Global and Community Health, George Mason University, Fairfax, Virginia.
Abstract
OBJECTIVES: To evaluate the survival and neurodevelopmental impairment (NDI) in extremely low birth weight (ELBW) infants at 18 to 26 months with early hypoxemic respiratory failure (HRF). We also assessed whether African American infants with early HRF had improved outcomes after exposure to inhaled nitric oxide (iNO). METHODS: ELBW infants ≤1000 g and gestational age ≤26 weeks with maximal oxygen ≥60% on either day 1 or day 3 were labeled as "early HRF" and born between 2007 and 2015 in the Neonatal Research Network were included. Using a propensity score regression model, we analyzed outcomes and effects of exposure to iNO overall and separately by race. RESULTS: Among 7639 ELBW infants born ≤26 weeks, 22.7% had early HRF. Early HRF was associated with a mortality of 51.3%. The incidence of moderate-severe NDI among survivors was 41.2% at 18 to 26 months. Mortality among infants treated with iNO was 59.4%. Female sex (adjusted odds ratio [aOR]: 2.4, 95% confidence interval [CI]: 1.8-3.3), birth weight ≥720 g (aOR: 2.3, 95% CI: 1.7-3.1) and complete course of antenatal steroids (aOR: 1.6, 95% CI: 1.1-2.2) were associated with intact survival. African American infants had a similar incidence of early HRF (21.7% vs 23.3%) but lower exposure to iNO (16.4% vs 21.6%). Among infants with HRF exposed to iNO, intact survival (no death or NDI) was not significantly different between African American and other races (aOR: 1.5, 95% CI: 0.6-3.6). CONCLUSIONS: Early HRF in infants ≤26 weeks' gestation is associated with high mortality and NDI at 18 to 26 months. Use of iNO did not decrease mortality or NDI. Outcomes following iNO exposure were not different in African American infants.
OBJECTIVES: To evaluate the survival and neurodevelopmental impairment (NDI) in extremely low birth weight (ELBW) infants at 18 to 26 months with early hypoxemic respiratory failure (HRF). We also assessed whether African American infants with early HRF had improved outcomes after exposure to inhaled nitric oxide (iNO). METHODS: ELBW infants ≤1000 g and gestational age ≤26 weeks with maximal oxygen ≥60% on either day 1 or day 3 were labeled as "early HRF" and born between 2007 and 2015 in the Neonatal Research Network were included. Using a propensity score regression model, we analyzed outcomes and effects of exposure to iNO overall and separately by race. RESULTS: Among 7639 ELBW infants born ≤26 weeks, 22.7% had early HRF. Early HRF was associated with a mortality of 51.3%. The incidence of moderate-severe NDI among survivors was 41.2% at 18 to 26 months. Mortality among infants treated with iNO was 59.4%. Female sex (adjusted odds ratio [aOR]: 2.4, 95% confidence interval [CI]: 1.8-3.3), birth weight ≥720 g (aOR: 2.3, 95% CI: 1.7-3.1) and complete course of antenatal steroids (aOR: 1.6, 95% CI: 1.1-2.2) were associated with intact survival. African American infants had a similar incidence of early HRF (21.7% vs 23.3%) but lower exposure to iNO (16.4% vs 21.6%). Among infants with HRF exposed to iNO, intact survival (no death or NDI) was not significantly different between African American and other races (aOR: 1.5, 95% CI: 0.6-3.6). CONCLUSIONS: Early HRF in infants ≤26 weeks' gestation is associated with high mortality and NDI at 18 to 26 months. Use of iNO did not decrease mortality or NDI. Outcomes following iNO exposure were not different in African American infants.
Authors: Krisa P Van Meurs; Linda L Wright; Richard A Ehrenkranz; James A Lemons; M Bethany Ball; W Kenneth Poole; Rebecca Perritt; Rosemary D Higgins; William Oh; Mark L Hudak; Abbot R Laptook; Seetha Shankaran; Neil N Finer; Waldemar A Carlo; Kathleen A Kennedy; Jon H Fridriksson; Robin H Steinhorn; Gregory M Sokol; G Ganesh Konduri; Judy L Aschner; Barbara J Stoll; Carl T D'Angio; David K Stevenson Journal: N Engl J Med Date: 2005-07-07 Impact factor: 91.245
Authors: Regan E Giesinger; Kiran More; Jodie Odame; Amish Jain; Robert P Jankov; Patrick J McNamara Journal: Pediatr Res Date: 2017-10-04 Impact factor: 3.756
Authors: Lisa M Askie; Lucy C Davies; Michael D Schreiber; Anna Maria Hibbs; Philip L Ballard; Roberta A Ballard Journal: J Pediatr Date: 2017-12-11 Impact factor: 4.406
Authors: Veena Manja; Gordon Guyatt; Satyan Lakshminrusimha; Susan Jack; Haresh Kirpalani; John A F Zupancic; Dmitry Dukhovny; John J You; Sandra Monteiro Journal: J Perinatol Date: 2018-10-23 Impact factor: 2.521